S. Spiro (Middlesex, United Kingdom), R.M. Huber (Munich, Germany)
LATE-BREAKING ABSTRACT: Interval lung cancers not detected on screening chest x-rays: How are they different?
P. A. Kvale, C. Cole Johnson, M. Tammemagi, P. M. Marcus, C. J. Zylak, D. L. Spizarny, W. Hocking, M. Oken, J. Commins, L. Ragard, P. Hu, C. Berg, P. Prorok (Detroit, Bethesda, Marshfield, Minneapolis, Rockville, United States Of America; St. Catharines, Canada)
|   ![]()  ![]() |
LATE-BREAKING ABSTRACT: The effect of route of presentation on lung cancer outcome
L. Succony, E. Swanson, S. Gauntett, J. Ramsay (Luton, United Kingdom)
| ![]() ![]() |
The results of the prevalence screen in Lung SEARCH: A UK based screening trial for lung cancer based on sputum cytology and cytometry, by the Lung SEARCH screening group
S. Spiro (London, United Kingdom)
| |
Detection of lung cancer using ion mobility spectrometry in Japan: A pilot study
H. Handa, T. Miyazawa, K. Morikawa, T. Inoue, N. Furuya, H. Kida, H. Nishine, S. Nobuyama, T. Inoue, M. Mineshita, T. Hiramoto (Kawasaki, Japan)
| |
Cancer-associated oncogenic BARD1 isoforms: From biomarker expression studies to development of a blood test for early detection of lung cancer
I. Irminger-Finger, P.A. André, M. Piyugin, B. Hegedus, F. Piantedosi, G. Laurent, A. Bianco (Geneva, Switzerland; Vienna, Austria; Naples, Campobasso, Italy; London, United Kingdom)
| |
Electronic nose detects early stage and peripheral lung cancers
A. Dent, R. Bowman, P. Zimmerman, I. Yang, K. Fong (Brisbane, Australia)
| ![]() ![]() |
An electronic nose in the discrimination of patients with lung cancer and controls
M. Bukovskis, G. Strazda, U. Kopeika, N. Jurka, L. Balode, I. Taivans (Riga, Latvia)
| |
Hyaluronan: A novel sputum marker for the screening and diagnosis of lung cancer patients
M. Peres Rangel, V. Karen de Sá, J.R. Maciel Martins, E.R. Parra Cuentas, R. Vieira Reis, A. Longatto Filho, T. Takagaki, H. Nader, V.L. Capelozzi (Sao Paulo, , Barretos, Brazil)
| |